Sign up to get notified if we do in the future.
We guarantee the lowest price on all of our prescription products. If you find your medications cheaper at any other recognized licensed mail order pharmacy, we will not only match their price, we will beat it by 25% of the difference. It is our 125% price match guarantee!
Example: If you find a product on Canada Drugs Direct for $50.00 and find the same product for $40.00 at another mail order pharmacy, we will provide you with a $12.50 discount, bringing your total to $37.50.
To get the discount please make sure to mention the price match to the customer service team when they call to collect payment for your order. Or call toll free at 1-888-904-8467 to place the order through the phone.
Terms & Conditions of Program
A generic drug is a copy of the brand-name drug with the same dosage, safety, strength, quality, consumption method, performance, and intended use. Before generics become available on the market, the generic company must prove it has the same active ingredients as the brand-name drug and works in the same way and in the same amount of time in the body.
The only differences between generics and their brand-name counterparts is that generics are less expensive and may look slightly different (eg. different shape or color), as trademarks laws prevent a generic from looking exactly like the brand-name drug.
Generics are less expensive because generic manufacturers don't have to invest large sums of money to develop a drug. When the brand-name patent expires, generic companies can manufacture a copy of the brand-name and sell it at a substantial discount.
Gazyva (obinutuzumab) is a treatment that is used with chemotherapy in adults who have follicular lymphoma (FL) that has not been previously treated, did not respond to treatment, or have FL that has returned after receiving treatment. Gazyva is also used with chemotherapy to treat chronic lymphocytic leukemia in adults who have not yet received treatment for it.
Gazyva is administered via an intravenous infusion.
Gazyva comes in 1000 mg/40 mL vials for single dosing. The Gazyva package insert should accompany the vials. Your dose and treatment duration will be determined by your healthcare provider. Your healthcare provider may also prescribe medications for infusion-related reactions and tumor lysis syndrome that you take before you receive your Gazyva infusion.
Gazyva will be administered as an intravenous infusion by your healthcare provider.
Talk to your healthcare provider if you have any questions or concerns.
The active ingredient in Gazyva is obinutuzumab.
Patients who have had allergic reactions to Gazyva or any of its excipients, including serum sickness with previous use, should not receive the medication.
Gazyva side effects include but are not limited to infusion-related reactions, decreased neutrophils, fatigue, cough, upper respiratory tract infections, musculoskeletal pain, constipation, and diarrhea. Inform your healthcare provider right away if you have worrisome or persistent side effects.
Talk to your healthcare provider about Gazyva.
Gazyva. South San Francisco, CA: Genentech, Inc.; 2022.